Seed funding falling short: BioCrossroads to offer $6 million less than originally hoped
It’s the Catch-22 of entrepreneurship. Attracting investment money is most difficult during the earliest days, exactly when startups need it most. BioCrossroads hopes to break that tricky cycle with its new $4 million seed-stage venture capital fund, Indiana Seed Fund I. But when fund raising was launched last year, the life sciences initiative aimed for $10 million. At about $250,000 per deal, BioCrossroads can do up to 15 deals-or two dozen fewer than it had intended. “We would certainly have…